Christabel Esi Damoah

Christabel Esi Damoah serves as a Research Fellow in the Department of Clinical Medicine at UiT The Arctic University of Norway, Tromsø, actively contributing to the Thrombosis Research Group (TREC) and Milestone VTE project with a focus on venous thromboembolism pathogenesis.

Her research centers on the complement lectin pathway's role in VTE, specifically investigating how MBL/MASPs complexes drive thrombotic mechanisms. She employs biochemical, epidemiological, and cell-based approaches to identify predictive biomarkers and elucidate pathological pathways in thrombosis.

Recent publications (2021-2025) consistently explore complement system biomarkers (MBL, MASP-2) as indicators of VTE risk, with studies published in Arteriosclerosis, Thrombosis and Vascular Biology demonstrating interdisciplinary connections between immunology and hemostasis.

Dr. Damoah collaborates extensively within TREC and the Milestone VTE initiative. While specific grant details remain unreported, her work is institutionally supported through UiT's Department of Clinical Medicine. No formal advisees are documented in available sources.

Her laboratory research operates within the Thrombosis Research Group (TREC), which investigates thrombosis mechanisms and hemostasis regulation, alongside the Milestone VTE project focused on improving VTE diagnostic frameworks and clinical management strategies.